1. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia

   • Mona Anand
   • Niharendu Ghara
   • Atul Sharma

   Original Article 12 November 2005 Pages: 767 - 770

   

2. Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells

   • Wolfgang E. Berdel
   • Emma Kulimova
   • Elisabeth Oelmann

   Original Article 12 November 2005 Pages: 771 - 773

   

3. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid

   • C. F. Classen
   • A. Teigler-Schlegel
   • K. M. Debatin

   Original Article 12 November 2005 Pages: 774 - 780

   

4. Over-representation of bcr3 subtype of PML/RARα fusion gene in APL in Indian patients

   • Sudha Sazawal
   • Syed Khizer Hasan
   • Renu Saxena

   Original Article 12 November 2005 Pages: 781 - 784

   

5. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients

   • Ulrike Bacher
   • Wolfgang Kern
   • Torsten Haferlach

   Original Article 12 November 2005 Pages: 785 - 791

6. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia

   • G. Specchia
   • D. Pastore
   • V. Liso

   Original Article 12 November 2005 Pages: 792 - 795

7. Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study

   • Hannes Müller-Beißenhirtz
   • Christoph Kasper
   • Ulrich Dührsen

   Original Article 12 November 2005 Pages: 796 - 801

   

8. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample

   • Esmeralda Vizzi
   • Carmen Luisa Loureiro
   • Flor Helene Pujol

   Original Article 12 November 2005 Pages: 802 - 806

   

9. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura

   • Yutaka Tsutsumi
   • Hiroe Kanamori
   • Nobuo Masauzi

   Original Article 12 November 2005 Pages: 807 - 811

10. Complement profile in childhood immune thrombocytopenic purpura: a prospective pilot study

    • Meli Ohali
    • Yair Maizlish
    • Gilles Lugassy

    Original Article 12 November 2005 Pages: 812 - 815

11. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard–Soulier syndrome

    • Margareth Castro Ozelo
    • Pavel Svirin
    • Lubov Larina

    Original Article 12 November 2005 Pages: 816 - 822

    

12. Evaluation of a novel case-based training program (d3web.Train) in hematology

    • Doris Kraemer
    • Stanislaus Reimer
    • Christian Kneitz

    Original Article 12 November 2005 Pages: 823 - 829

    

13. Occurrence of multiple myeloma 13 years after Hodgkin’s disease: chance or consequence?

    • Eva-Susanne Strobel
    • Kris Bauchmüller
    • Monika Engelhardt

    Letter to the Editor 12 November 2005 Pages: 830 - 832

14. Treatment with valproic acid for myelofibrosis with myeloid metaplasia

    • Yasuyuki Inoue
    • Takao Suzuki
    • Masatomo Takahashi

    Letter to the Editor 12 November 2005 Pages: 833 - 834

    

15. Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease

    • Jacek Treliński
    • Krzysztof Chojnowski
    • Tadeusz Robak

    Letter to the Editor 12 November 2005 Pages: 835 - 836

    

16. Acknowledgement to Referees

    Acknowledgement to Referees 12 November 2005 Pages: 837 - 837